RESEARCH SITES AND SPONSORS COOPERATE TO PREVENT PROFESSIONAL RESEARCH SUBJECTS IN CNS CLINICAL TRIALS BY USING VERIFIED CLINICAL TRIALS

Duplicate subjects, or what is known as professional research subjects, exist in most clinical trials to varying degrees. CNS clinical trials are especially prone to duplicate subjects or over enrollment in clinical tials. The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications. Use of global …

Read more

Strategies To Proactively Detect And Prevent Professional Research Subjects With Verified Clinical Trials Research Subject Database Registry

Clinical trials around the world face challenges from professional research subjects or dual enrollment in clinical trials. One group of subjects that have high rates of participation in clinical research are subjects who enroll in multiple trials for the purpose of generating income through study payments or using clinical trials as medical care. These subjects …

Read more

Screen Shot 2019 06 15 at 9.25.12 AM

Case Study: Duplicate Subjects In Clinical Trials Cause Failure To Meet Endpoints

Your clinical trial is not meeting it’s endpoints and upon review, you detect there are duplicate subjects in your study. You and your teams spend several months trying to weed out these duplicate subjects. A new study must be performed. We hear this all the time. It occurs across most therapeutic indications and across the …

Read more

Key Research Sites In Germany Join Verified Clinical Trials Research Subject Registry To Prevent Duplicate Subjects & Over Enrollment To Improve Safety & Data Quality

Several premier research centers in Germany have led the initiative and joined the global Verified Clinical Trials (VCT) research subject database registry to prevent duplicate subjects and other important protocol violations in an effort to improve safety and data quality in their clinical trials. Key research sites in Germany join Verified Clinical Trials to prevent …

Read more

Screen Shot 2019 05 30 at 12.33.36 PM

Understanding Research Subjects Behaviors & Travel Habits: Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) presented a poster at the ASCP meeting in Phoenix May 2019, detailing travel habits and distances specifically in CNS clinical trials. Bottom line: In many instances, research subjects travel large distances to become duplicate subjects in CNS clinical trials. A research subject database is needed to prevent duplicate subjects and many …

Read more

Screen Shot 2019 05 14 at 8.39.59 PM

Protect Your Clinical Trials Against Duplicate Subjects and Professional Research Subjects

If you protect your computers against malware and viruses, why not protect your clinical trials from duplicate subjects that cause data quality and safety issues as well as failed clinical trials?  Verified Clinical Trials (VCT) is the leading global research subject database to prevent duplicate subjects in clinical trials  also known as professional research subjects. …

Read more

Screen Shot 2018 04 19 at 3.41.36 PM

Duplicate Subjects In CNS Clinical Trials and Other Therapeutic Areas Prevented With Verified Clinical Trials Research Subject Database Registry

From phase 1 through phase 4 drug development, the issue of duplicate subjects in clinical trials exists.  Verified Clinical Trials (VCT). www.verifiedclinicaltrials.com is here to prevent these issues and promote safety and data quality.  Duplicate subjects in CNS clinical trials is especially needed, but VCT protects most therapeutic areas. Characteristics of duplicate subjects are not …

Read more

Screenshot 2017 06 03 09.56.26 1

Duplicate Subjects In Clinical Trials Can Be Prevented With A Global Research Subject Registry

Duplicate subjects in clinical trials is unfortunately a common issue that affects all trials from most every indication and across all phases of clinical trials research.  These professional research subjects can be prevented by using Verified Clinical Trials (VCT) the global research subject registry.  Nearly all of the phase 1 units across the United States …

Read more

Screen Shot 2019 03 31 at 10.34.14 PM

Having a system, or research subject database registry, to proactively detect and prevent duplicate subjects and other protocol violations has become a well recognized and important step to protect the data quality and improve research subject safety. This is NOT limited to phase 1 healthy volunteer studies. This happens with significant frequency across multiple therapeutic …

Read more

Screen Shot 2019 03 16 at 3.15.28 PM

Using Verified Clinical Trials’ Database Registry to Determine the Prevalence of and Prevent Inclusion/Exclusion Related Protocol Violations in Early Phase Clinical Trials

Yulan Zhang from Verified Clinical Trials presenting a poster at #ASCPT2019 “Using Verified Clinical Trials’ Database Registry to Determine the Prevalence of and Prevent Inclusion/Exclusion Related Protocol Violations in Early Phase Clinical Trials”. VCT prevents duplicate subjects in clinical trials. The data demonstrates how VCT prospectively determines the prevalence of and prevent inclusion/exclusion related protocol …

Read more